GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Axogen Inc (FRA:LT3) » Definitions » Cyclically Adjusted PS Ratio

Axogen (FRA:LT3) Cyclically Adjusted PS Ratio : 2.73 (As of Jun. 19, 2024)


View and export this data going back to 2016. Start your Free Trial

What is Axogen Cyclically Adjusted PS Ratio?

As of today (2024-06-19), Axogen's current share price is €6.80. Axogen's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was €2.49. Axogen's Cyclically Adjusted PS Ratio for today is 2.73.

The historical rank and industry rank for Axogen's Cyclically Adjusted PS Ratio or its related term are showing as below:

FRA:LT3' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 1.4   Med: 4.84   Max: 28.06
Current: 2.68

During the past years, Axogen's highest Cyclically Adjusted PS Ratio was 28.06. The lowest was 1.40. And the median was 4.84.

FRA:LT3's Cyclically Adjusted PS Ratio is ranked worse than
56.39% of 477 companies
in the Medical Devices & Instruments industry
Industry Median: 2.12 vs FRA:LT3: 2.68

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Axogen's adjusted revenue per share data for the three months ended in Mar. 2024 was €0.881. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is €2.49 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Axogen Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Axogen's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Axogen Cyclically Adjusted PS Ratio Chart

Axogen Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 10.45 9.64 4.83 4.32 2.58

Axogen Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.92 3.67 1.94 2.58 2.91

Competitive Comparison of Axogen's Cyclically Adjusted PS Ratio

For the Medical Devices subindustry, Axogen's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Axogen's Cyclically Adjusted PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Axogen's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Axogen's Cyclically Adjusted PS Ratio falls into.



Axogen Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Axogen's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=6.80/2.49
=2.73

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Axogen's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Axogen's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.881/131.7762*131.7762
=0.881

Current CPI (Mar. 2024) = 131.7762.

Axogen Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 0.178 100.560 0.233
201409 0.208 100.428 0.273
201412 0.209 99.070 0.278
201503 0.203 99.621 0.269
201506 0.229 100.684 0.300
201509 0.271 100.392 0.356
201512 0.239 99.792 0.316
201603 0.243 100.470 0.319
201606 0.307 101.688 0.398
201609 0.331 101.861 0.428
201612 0.332 101.863 0.429
201703 0.347 102.862 0.445
201706 0.408 103.349 0.520
201709 0.404 104.136 0.511
201712 0.424 104.011 0.537
201803 0.405 105.290 0.507
201806 0.480 106.317 0.595
201809 0.504 106.507 0.624
201812 0.531 105.998 0.660
201903 0.529 107.251 0.650
201906 0.603 108.070 0.735
201909 0.659 108.329 0.802
201912 0.642 108.420 0.780
202003 0.553 108.902 0.669
202006 0.493 108.767 0.597
202009 0.708 109.815 0.850
202012 0.664 109.897 0.796
202103 0.640 111.754 0.755
202106 0.678 114.631 0.779
202109 0.640 115.734 0.729
202112 0.671 117.630 0.752
202203 0.673 121.301 0.731
202206 0.776 125.017 0.818
202209 0.884 125.227 0.930
202212 0.807 125.222 0.849
202303 0.804 127.348 0.832
202306 0.822 128.729 0.841
202309 0.899 129.860 0.912
202312 0.914 129.419 0.931
202403 0.881 131.776 0.881

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Axogen  (FRA:LT3) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Axogen Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Axogen's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Axogen (FRA:LT3) Business Description

Traded in Other Exchanges
Address
13631 Progress Boulevard, Suite 400, Alachua, FL, USA, 32615
Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically, economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, South Korea, and several other countries.

Axogen (FRA:LT3) Headlines

No Headlines